These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 16194413

  • 21. Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure.
    Kincaid-Smith P, Fairley KF, Packham D.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2272-4. PubMed ID: 15252156
    [Abstract] [Full Text] [Related]

  • 22. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O, Metelka R, Vymetal J, Konecný K, Kosatíková Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [Abstract] [Full Text] [Related]

  • 23. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y, Okada H, Saruta T, Suzuki H.
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [Abstract] [Full Text] [Related]

  • 24. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Locatelli F, Carbarns IR, Maschio G, Mann JF, Ponticelli C, Ritz E, Alberti D, Motolese M, Janin G, Zucchelli P.
    Kidney Int Suppl; 1997 Dec; 63():S63-6. PubMed ID: 9407424
    [Abstract] [Full Text] [Related]

  • 25. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 26. A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure.
    MacGregor MS, Deighan CJ, Rodger RS, Boulton-Jones JM.
    Nephron Clin Pract; 2005 Jan; 101(3):c139-49. PubMed ID: 16015004
    [Abstract] [Full Text] [Related]

  • 27. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J, Vítovec J, Soucek M, Dusek L, Pavlík T, CORD Invesigators.
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of the treatment: combination of benazepril/lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension.
    Chen T, Chen GH, Yang TS, Zhong ZY, An WS, Zhang XX, Li JD.
    Chin Med J (Engl); 2013 Jun; 126(12):2286-90. PubMed ID: 23786940
    [Abstract] [Full Text] [Related]

  • 29. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 30. [Suppressive effect of angiotensin converting enzyme inhibitor (ACEI) on the progression of renal insufficiency: a propensity score analysis].
    Hirabayashi A, Ogawa T, Urashima M, Sone M, Nihei H.
    Nihon Jinzo Gakkai Shi; 2004 Jan; 46(1):35-42. PubMed ID: 15007909
    [Abstract] [Full Text] [Related]

  • 31. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T, Fujiwara N, Kawagoe Y, Sugaya T, Ueda Y, Koide H.
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR, Yang Y, Wang SC, Chiu PF, Chou WY, Lin CY, Chang JM, Chen TW, Ferng SH, Lin CL.
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [Abstract] [Full Text] [Related]

  • 33. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M, Tylicki L, Rutkowski P, Wojnarowski K, Lysiak-Szydlowska W, Rutkowski B.
    Scand J Urol Nephrol; 2005 Mar; 39(6):511-7. PubMed ID: 16303729
    [Abstract] [Full Text] [Related]

  • 34. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC.
    Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
    [Abstract] [Full Text] [Related]

  • 35. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE, Cohen J, Vivera M, Zaltzman JS.
    Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
    [Abstract] [Full Text] [Related]

  • 36. Economic evaluation of benazepril in chronic renal insufficiency.
    van Hout BA, Simeon GP, McDonnell J, Mann JF.
    Kidney Int Suppl; 1997 Dec; 63():S159-62. PubMed ID: 9407447
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T, Pohl M, Misselwitz J, John U.
    Kidney Blood Press Res; 2009 Dec; 32(6):440-4. PubMed ID: 20016211
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of benazepril plus hydrochlorothiazide versus benazepril alone in hypertensive patients unresponsive to benazepril monotherapy.
    Holwerda K, Hoogma RP, Oldenbroek C, Huige RC, Wester A, Rijnierse JM.
    Clin Ther; 1994 Dec; 16(6):942-51. PubMed ID: 7697691
    [Abstract] [Full Text] [Related]

  • 39. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Dec; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 40. [Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study].
    Fang YQ, Lu Y, Wang YJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar; 32(3):311-6. PubMed ID: 22686073
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.